» Articles » PMID: 10483056

Association Between the Dopamine D4 Receptor (DRD4) Exon III Polymorphism and Measures of Novelty Seeking in a German Population

Overview
Journal Mol Psychiatry
Date 1999 Sep 14
PMID 10483056
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Since the observation of an association between the dopamine D4 receptor (DRD4) exon III polymorphism and the temperament trait of Novelty Seeking,1 replication studies have yielded both positive2-5 and negative6-12 results. This raised the question whether the initial findings must be regarded as false positives.13 However, demographic or methodological differences between studies may have obscured the small effect of the DRD4 polymorphism on Novelty Seeking.14 Examination of clinical or older cohorts may have led to an underestimation of possible associations due to a restricted variation of Novelty Seeking in these cohorts. The use of different questionnaires provides another source of variation. In order to replicate the initial findings as precisely as possible, a cohort of 136 healthy, young volunteers was genotyped, and Novelty Seeking was ascertained using the TPQ.15,16 In addition, further aspects of novelty seeking behavior have been ascertained through additional trait measures. We could observe the reported association between long DRD4 alleles and significantly elevated scores (age- and sex-residualized) on the TPQ-Novelty Seeking total scale as well as on two of the subscales, Exploratory Excitability and Extravagance. The results provide further confirmation for the role of the DRD4 exon III polymorphism in modulation of Novelty Seeking. In addition, the pattern of associations between the polymorphism and other scales suggests that this polymorphism has its effect on exploratory, extravagant, and extraverted, rather than on impulsive and monotony-avoidant subtypes of Novelty Seeking.

Citing Articles

Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance.

Huminska-Lisowska K Int J Mol Sci. 2024; 25(21).

PMID: 39519153 PMC: 11546834. DOI: 10.3390/ijms252111602.


Inhibitory framing in hypersexual patients with Parkinson's disease. An fMRI pilot study.

Theis H, Probst C, Campabadal A, S Goerlich K, Granert O, Wolff S Exp Brain Res. 2022; 240(7-8):2097-2107.

PMID: 35763033 PMC: 9288360. DOI: 10.1007/s00221-022-06397-5.


Exon 3 Gene Polymorphisms in Patients Diagnosed with Polysubstance Use Disorder and Co-Occurrence of a Depressive Episode.

Chmielowiec K, Chmielowiec J, Masiak J, Czekaj M, Krawczyk P, Soroka E Genes (Basel). 2021; 12(11).

PMID: 34828440 PMC: 8623079. DOI: 10.3390/genes12111834.


Associations between the dopamine D4 receptor gene polymorphisms and personality traits in elite athletes.

Michalowska-Sawczyn M, Niewczas M, Krol P, Czarny W, Rzeszutko A, Chmielowiec K Biol Sport. 2020; 36(4):365-372.

PMID: 31938008 PMC: 6945044. DOI: 10.5114/biolsport.2019.85457.


A neurocomputational account of reward and novelty processing and effects of psychostimulants in attention deficit hyperactivity disorder.

Sethi A, Voon V, Critchley H, Cercignani M, Harrison N Brain. 2018; 141(5):1545-1557.

PMID: 29547978 PMC: 5917772. DOI: 10.1093/brain/awy048.